StockData

VitaSpring Biomedical Co. Ltd. (VSBC) stock

VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.58MP/E –Yield –

VitaSpring Biomedical gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

VitaSpring Biomedical's gross profit for the twelve months ending Jan 31, 2024 was $0. For fiscal 2026 it was $0. The highest annual figure on record is $2.07M in fiscal 2022.

Annual gross profit

PeriodPeriod endValueChange
FY2026Jan 31, 2026$0–
FY2025Jan 31, 2025$0–
FY2024Jan 31, 2024$0–
FY2023Jan 31, 2023-$3.33M-261.2%
FY2022Jan 31, 2022$2.07M+1743.1%
FY2021Jan 31, 2021$112.20K+6519.5%
FY2020Jan 31, 2020$1.70K-87.6%
FY2019Jan 31, 2019$13.72K+21.0%
FY2018Jan 31, 2018$11.34K–
FY2017Jan 31, 2017$0–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2024CQ4 2023Jan 31, 2024$0–
Q3 FY2024CQ3 2023Oct 31, 2023$0–
Q2 FY2024CQ2 2023Jul 31, 2023$0–
Q1 FY2024CQ1 2023Apr 30, 2023$0-100.0%
Q4 FY2023CQ4 2022Jan 31, 2023-$3.90M-365.9%
Q3 FY2023CQ3 2022Oct 31, 2022$0-100.0%
Q2 FY2023CQ2 2022Jul 31, 2022$0-100.0%
Q1 FY2023CQ1 2022Apr 30, 2022$568.00K+136.9%
Q4 FY2022CQ4 2021Jan 31, 2022$1.47M+1207.5%
Q3 FY2022CQ3 2021Oct 31, 2021$20.00K–
Q2 FY2022CQ2 2021Jul 31, 2021$341.20K–
Q1 FY2022CQ1 2021Apr 30, 2021$239.80K–
Q4 FY2021CQ4 2020Jan 31, 2021$112.20K–
Q3 FY2021CQ3 2020Oct 31, 2020$0-100.0%
Q2 FY2021CQ2 2020Jul 31, 2020$0-100.0%
Q1 FY2021CQ1 2020Apr 30, 2020$0-100.0%
Q4 FY2020CQ4 2019Jan 31, 2020-$4.54K-294.5%
Q3 FY2020CQ3 2019Oct 31, 2019$3.54K+5428.1%
Q2 FY2020CQ2 2019Jul 31, 2019$3.54K+122.8%
Q1 FY2020CQ1 2019Apr 30, 2019$6.31K-35.1%
Q4 FY2019CQ4 2018Jan 31, 2019$2.34K+85.0%
Q3 FY2019CQ3 2018Oct 31, 2018$64-97.8%
Q2 FY2019CQ2 2018Jul 31, 2018$1.59K-18.7%
Q1 FY2019CQ1 2018Apr 30, 2018$9.73K+88.9%
Q4 FY2018CQ4 2017Jan 31, 2018$1.26K–
Q3 FY2018CQ3 2017Oct 31, 2017$2.97K–
Q2 FY2018CQ2 2017Jul 31, 2017$1.95K–
Q1 FY2018CQ1 2017Apr 30, 2017$5.15K–

More VitaSpring Biomedical figures

See a number that looks wrong?